Comparing apples and oranges  by Blackstone, Eugene H.
8 The Journal of Thoracic and Cardiovascular Surgery • January 2002
Mitral valve repair versus replacement, internal thoracic arteryversus saphenous vein graft conduits for coronary bypass,effect of chronic preoperative atrial fibrillation on outcome,gastric versus colon esophageal substitutes, complete versusincomplete off-pump revascularization, surgery in high- versuslow-volume centers, balloon versus surgical aortic valvotomy.
These are but a sample of studies of comparative outcome whose basis was clinical
experience rather than a formal clinical trial. Often, a cursory glance at patient char-
acteristics in each group reveals important differences that lead medical and statisti-
cal reviewers and readers alike to scoff, “They’re comparing ‘apples and oranges!’”
What does it take to convince the skeptic that the difference in outcome attrib-
uted to difference in treatment (or patient condition) is real? The answer to this
question is not academic; it can affect the way we as physicians learn to treat our
patients from studies of clinical experience.
When comparison is made in the context of a properly designed, appropriate,
ethical, feasible, well-analyzed, generalizable randomized trial, most of us would
accept a cause-and-effect linkage between treatment and difference in outcome. In
contrast, when the comparison emanates from studies of clinical experience—ubiq-
uitous in surgical experience and reporting—cause-and-effect attribution is consid-
ered “speculative” at best.
For 3 decades, multivariable risk factor analysis has been the mainstay for identi-
fying and quantifying treatment outcome differences adjusted for patient characteris-
tics. However, Kirklin and Barratt-Boyes1 recommended that these differences be
treated as associations with outcomes, not causes. There is no guarantee that risk fac-
tor analysis is an effective strategy for discovery of cause-and-effect mechanisms.2,3
During the 1980s, federal support for complex clinical trials in heart disease was
abundant. Few of us noticed important advances being made in statistical methods
for valid, nonrandomized comparisons. An example of the advances was the semi-
nal 1983 Biometrika article by Paul Rosenbaum at the University of Wisconsin,
Madison, and Donald Rubin at the University of Chicago, “The Central Role of the
Propensity Score in Observational Studies for Causal Effects.”4 In the 1990s, as the
funding climate changed, interest in methods for making nonrandomized compar-
isons accelerated.5-10
Recently, these methods have been recommended by statistical reviewers for
comparative clinical studies and have been adopted by some clinical research
groups. The result has been the introduction into our literature of unfamiliar meth-
ods with their unfamiliar terminology. Rather than being relieved that at last apples-
to-apples comparisons can be made with rigor, medical and sometimes statistical
reviewers, as well as readers, have become bewildered!
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Therefore, my purpose is to (1) clarify the nature of the
problem in nonrandomized comparisons that gives rise to
apples-and-oranges skepticism; (2) review previous
attempts to solve the problem; (3) present a method known
as balancing scores that can achieve apples-to-apples com-
parisons under some nonrandomized conditions; (4)
describe in nontechnical detail construction of the simplest
balancing score, the propensity score; (5) demonstrate how
the propensity score is used; and (6) discuss limitations, pit-
falls, and alternatives.
Nature of the Problem
Except by chance, characteristics differ among patients
constituting comparison groups of interest in nonrandom-
ized studies. (For lack of a better term, I use the phrase com-
parison group of interest throughout the text to indicate
either a treatment or procedure difference of interest or a
patient characteristic difference of interest, such as whether
a patient is in chronic atrial fibrillation). These differences
in characteristics between groups are often large, system-
atic, and statistically significant. They arise from clinically
motivated patient selection. (How often does the clinical
inferences section of a journal article begin, “In carefully
selected patients. . . ?”) They arise for undocumented rea-
sons called “treatment variance.” They sometimes arise by
chance. In whatever way they arise, they invalidate direct
comparisons.
For example, Table 1 contrasts a few characteristics of
patients referred for stress echocardiography who reported
they either were or were not receiving long-term aspirin
therapy. A clinically relevant question might be, “Does
long-term aspirin use convey a survival benefit, and if so,
for whom?” However, a glance at the table of patient char-
acteristics makes the reader justifiably suspicious of
attributing outcome difference to aspirin treatment in such
obviously selected patients. “True, true, and unrelated,”
says one. “Apples and oranges,” says another. 
Comparisons based on well-designed randomized studies
provide at least 6 protections not available to the clinical
investigator that increase the cause-effect believability of a
comparison.11,12 (1) Entry and exclusion criteria are pre-
scribed and identical for the groups being compared; thus,
the variables used to assign treatment are known. (2) All
patients have a specified chance of receiving each treatment,
avoiding both obvious and nonobvious clinical selection of
patients for one treatment or the other. (3) Treatments are
concurrent, avoiding temporal trends. (4) Data collection is
concurrent, uniform, and high quality, eliminating differ-
ences in definition or types of variables collected. (5)
Unrecorded variables affecting outcome are nearly equally
distributed between groups, eliminating confounding (one of
the most important benefits of randomization). (6)
Assumptions underlying statistical comparison tests are met. 
None of these protections is available in making nonran-
domized comparisons. So, why not mount randomized trials
for every question? Without elaborating the limitations of ran-
domized trials (but pointing out that some comparisons, such
as whether or not a person goes into atrial fibrillation, cannot
be randomized), let us acknowledge that it is impossible to
mount a randomized trial to address every comparison.13
Can anything be done to increase the credibility of com-
parative studies based on clinical experience rather than
randomized trials?
Previous Attempts to Address the Problem
Matching
A possibly familiar method for making nonrandomized
comparisons is the case-control study.14,15 The method
seems logical and straightforward in concept. Patients in
one treatment group (cases) are matched with one or more
patients in the other treatment group (controls) according to
variables such as age, sex, and ventricular function.
However, case matching is rarely easy in practice. How
close in age is acceptable? How close in ejection fraction?
“We don’t have anyone to match this patient in both age and
ejection fraction!” The more variables that need to be
matched, the more difficult it is to find a match in all spec-
ified characteristics! Yet, matching on only a few variables
may not protect well against apples-and-oranges compar-
isons.16-18 Diabolically, selection factor effects (called
bias), which case-matching is intended to reduce, may
increase bias if unmatched cases are simply eliminated.19
Multivariable Analysis
Treatment differences in outcome may instead be identified
by multivariable analysis. Such analyses examine many
variables simultaneously, including the comparison variable
of interest. If one is fortunate, multivariable analysis will
eliminate selection factors and provide an accurate assess-
ment of the effect of the comparison variable of interest,
TABLE 1. Selected patient characteristics according to
long-term aspirin use in patients undergoing stress
echocardiography for known or suspected coronary artery
disease
ASA No ASA
Patient characteristic (n = 2455) (n = 4072) P
Men (%) 49 56 .001
Age (y, mean ± SD) 62 ± 11 56 ± 12 <.0001
Smoker (%) 10 13 .001
Resting heart rate (beats/min) 74 ± 13 78 ± 14 <.0001
Ejection fraction (%) 50 ± 9 53 ± 7 <.0001
ASA, Long-term aspirin use; SD, standard deviation.
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properly adjusted for patient characteristic differences.
However, until now there has been no test to determine
whether we have been fortunate.2,18,20,21
Balancing Scores to the Rescue
Apples-to-apples nonrandomized comparisons of outcome
can be achieved, within certain limitations, by use of so-
called balancing scores.4 Balancing scores are a class of
multivariable statistical methods that identify patients with
similar chances of receiving one or the other treatment, per-
mitting nonrandomized comparisons of treatment outcomes.
The developers of balancing score methods claim that
the difference in outcome between patients who have a sim-
ilar balancing score, but receive different treatments, pro-
vides an unbiased estimate of the effect attributable to the
comparison variable of interest.4 That is technical jargon for
saying that the method can identify the apples from among
the mixed fruit of clinical practice variance, transforming an
apples-to-oranges outcomes comparison into an apples-to-
apples comparison.22-25
Astonishing!
Why Is It Called a Balancing Score?
Randomly assigning patients to alternative treatments in
clinical trials balances both patient characteristics (at least
in the long run) and number of subjects in each treatment
arm. In a nonrandomized setting, neither patient character-
istics nor number of patients is balanced for each treatment.
A balancing score achieves local balance in patient charac-
teristics at the expense of unbalancing n.
Table 2 illustrates local balance of patient characteristics
achieved by using a specific balancing score known as the
propensity score (see below for details). The propensity score
quantified each patient’s probability (propensity) of being on
long-term aspirin therapy. Patients were divided into 5 equal-
sized groups called quintiles, on the basis of having similar
propensity scores (use of quintiles has a statistical rationale).4
Simply by virtue of having similar propensity scores, patients
within each quintile were found to have similar characteris-
tics (except for age in quintile I). As might be expected,
patient characteristics differed importantly from one quintile
to the next; for example, most of quintile I was women; most
of quintile V was men. These quintiles look like 5 individual
randomized trials with differing entry and exclusion criteria,
which is exactly what balancing scores are intended to
achieve! Thus, the propensity score balanced essentially all
patient characteristics within localized subsets of patients. 
To achieve this balance, a widely dissimilar number of
patients actually received long-term aspirin therapy from
quintile to quintile. Quintile I contained only a few patients
who received long-term aspirin therapy, whereas quintile V
had few not receiving aspirin. Thus, balance in patient char-
acteristics was achieved by unbalancing n.
Propensity Score
The most widely used balancing score is the propensity
score.4 For each patient, it provides an estimate of the
propensity toward (probability of) belonging to one group
versus another (group membership). In this section I will
describe (1) constructing a propensity model, (2) calculat-
ing a propensity score for each patient using the propensity
model, and (3) using the propensity score in various ways
for balancing. 
Hard Hat Area: Propensity Model Construction
For a 2-group comparison, multivariable logistic regression
is used to identify factors predictive of group membership.4
In most respects, this is what cardiothoracic groups have
done for years: find correlates of (risk factors for) an event.
In this case, the event is actual membership in one or the
other comparison group of interest. 
I recommend initially formulating a parsimonious
explanatory model that identifies the common denomina-
tors of group membership. Parsimonious means “simple,”
TABLE 2. Selected patient characteristics according to long-term aspirin use in patients undergoing stress echocardiog-
raphy for known or suspected coronary artery disease
Quintile I Quintile II Quintile III Quintile IV Quintile V
Patient ASA No ASA ASA No ASA ASA No ASA ASA No ASA ASA No ASA
characteristic (n = 113) (n = 1092) (n = 194) (n = 1111) (n = 384) (n = 922) (n = 719) (n = 586) (n = 1045) (n = 261)
Men (%) 22 22 57 63 74 71 78 78 88 87
Age (y) 55 49 56 55 61 61 62 64 63 65
Smoker (%) 15 13 15 15 12 11 11 13 7 9
Resting heart rate 84 83 79 79 76 76 76 76 71 73
(beats/min)
Ejection fraction (%) 53 54 54 54 53 53 49 49 49 48
Patients are grouped in quintiles according to a balancing (propensity) score. ASA, Long-term aspirin use.
Blackstone Statistics for the Rest of Us
The Journal of Thoracic and Cardiovascular Surgery • Volume 123, Number 1   11
TX
ET
CS
P
A
CD
CH
D
G
TS
ED
IT
O
RI
A
L
meaning a model limited to factors deemed statistically sig-
nificant. Model means a mathematical representation or
equation. (See the incremental risk factor concept in chap-
ter 6 of Cardiac Surgery.1) 
Once this traditional modeling is completed, a further
step is taken to generate the propensity model. The tradi-
tional model is augmented by other factors, even if not sta-
tistically significant. Thus, the propensity model is not
parsimonious.22 The goal is to balance patient characteris-
tics by incorporating “everything” recorded that may relate
to either systematic bias or simply bad luck.17
When taken to the extreme, forming the propensity model
can cause problems, because medical data tend to have many
variables that measure the same thing. The solution is to pick
one variable from among a closely related cluster of vari-
ables as a representative of the cluster. For example, select
one variable representing body size from among height,
weight, body surface area, and body mass index.
When a propensity model is being formed, information
should not be thrown away. Some biostatistical collabora-
tors dichotomize (group) continuous variables, such as age
or weight. This throws away information. Rather, the
propensity model should incorporate continuous variables
so as to produce a smooth distribution of scores necessary
for good local matching.
Other construction tips are presented in the appendix.
Calculating the Propensity Score
Once the propensity modeling is completed, the propensity
score is calculated for each patient. The procedure is simi-
lar to that used to calculate, for a given patient, expected
hospital mortality for coronary artery bypass grafting from
the Society of Thoracic Surgeons risk equation.26 
A logistic regression analysis, such as used for the
propensity model, generates a coefficient for each variable.
The coefficient maps the units of measurement of the vari-
able into units of risk.1 Specifically, a given patient’s value
for a variable is transformed into risk units by multiplying
it by the coefficient. For example, if the coefficient is 1.13
and the variable is “male” with a value of 1 (for “yes”), the
result will be 1.13 risk units. If the coefficient is 0.023 for
the variable “age” and a patient is 61.3 years old, 0.023
times 61.3 is 1.41 risk units. 
One continues through the list of model variables, multi-
plying the coefficient by the specific value for each vari-
able. When finished, the resulting products are summed. To
this sum is added the intercept of the model. The final score
is the propensity score. Its units are logit units, a word
coined by Berkson,27 formerly of the Mayo Clinic.
Using the Propensity Score for Comparisons
Once the propensity model is constructed and a propensity
score is calculated for each patient, 3 common types of
comparison are employed: matching, stratification, and
multivariable adjustment. 
Matching
The propensity score can be used as the sole criterion for
matching pairs of patients.6,28
Rarely does one find exact matches. Instead, a patient is
selected from the control group whose propensity score is
nearest to that of a patient in the case group. If multiple
patients are close in propensity scores, optimal selection
among these candidates can be used.23 Remarkably, problems
of matching on multiple variables disappear by compressing
“everything known about the patient” into a single score! 
Table 3 demonstrates that such matching works aston-
ishingly well. The comparison data sets have all the appear-
ances of a randomized study!
However, unlike a randomized study, the method is
unlikely to balance unmeasured variables well. My col-
leagues and I have built propensity models that purposely
exclude variables. When this is done, and the variables
excluded are not part of a closely correlated cluster (such as
body size), matched pairs differ significantly with respect to
these excluded variables. In addition, about 2% to 3% of
measured variables, despite being represented in the
propensity model, are dissimilar (P < .05) in the matched
groups. Nevertheless, this is remarkably superior to previ-
ous methods of matching. 
The average effect of the comparison variable of interest
is assessed as the difference in outcome between the groups
of matched pairs.
Stratification (Subclassification)
Outcome can be compared within broad groupings of
patients, called strata or subclasses, according to propensity
score.8,10,22 After patients are sorted by propensity score,
they are divided into equal-sized groups. For example, they
may be split into 5 groups, or quintiles (see Table 2), but
fewer or more may be used. Comparison of outcome for the
comparison variable of interest is made within each stratum. 
TABLE 3. Comparison of patient characteristics according
to long-term aspirin use in matched pairs according solely
to propensity score
Patient characteristic ASA (n = 1351) No ASA (n = 1351)
Men (%) 49 51
Age (y) 60 61
Smoker (%) 50 50
Resting heart rate (beats/min) 77 76
Ejection fraction (%) 51 51
ASA, Long-term aspirin use.
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If a consistent difference in outcome is not observed
across strata, intensive investigation is required. Usually,
something is discovered about the characteristics of the dis-
ease, the patients, or the clinical condition that results in a
different outcome.
Multivariable Adjustment
The propensity score for each patient can be included in a mul-
tivariable analysis of outcome.5,7,20 Such an analysis includes
both the comparison variable of interest and the propensity
score. The propensity score adjusts the apparent influence of
the comparison variable of interest for patient selection differ-
ences not accounted for by other variables in the analysis. 
Occasionally, the propensity score remains statistically
significant in such a multivariable model. This occurrence
constitutes evidence that adjustment for selection factors by
multivariable analysis alone is ineffective. This does not
happen often, but when it does, it is something that cannot
be ignored.3 It may mean that not all variables important for
bias reduction have been incorporated into the model, such
as when one is using a simple set of variables. It may mean
that an important modulating or synergistic effect of the
comparison variable occurs across propensity scores as
noted above. For example, the mechanism of disease may
be different within the quintiles. It may mean that important
interactions of the variable of interest with other variables
have not have been accounted for, leading to a systematic
difference identified by the propensity score. 
In some settings in which the number of events is small,
the propensity score can be used as the sole means of
adjusting for the variable representing the groups being
compared.17
Get Rid of Oranges?
The propensity score may reveal that a large number of
patients in one group do not have scores close to patients in
the other.29 If propensity matching is used, some patients
may not be matched. If stratification is used, quintiles of
patients may have hardly any matches at one or the other or
both ends of the propensity spectrum.
The knee-jerk reaction is to infer that these unmatched
patients represent, indeed, apples and oranges, unsuited for
direct comparison. Resist the urge to neglect these unmatch-
able patients!19 The most common reason for lack of
matches is that a strong surrogate for the comparison group
variable has been included inadvertently in the propensity
score (see appendix). This variable must be removed and
the propensity model revised.
If this is not the case, the analysis may indeed have iden-
tified truly unmatchable cases (mixed fruit). In some set-
tings in which my colleagues and I have observed this
phenomenon, it represented a different end of the spectrum
of disease for which different therapies had been applied
systematically. Often the first clue to this “anomaly” is find-
ing that the influence of the comparison variable of interest
is inconsistent across quintiles. 
Thus, when apples and oranges and other mixed fruit are
revealed by a propensity analysis, investigation should be
intensified rather than the oranges simply being set aside.
After the investigations are over, comparisons among the
well-matched patients can proceed while at the same time
the reader can be provided with the boundaries within
which a valid comparison was possible.
Limitations, Pitfalls, Alternatives
Randomized Trials
Balancing score methods are not substitutes for properly
designed, ethical, randomized clinical trials. They cannot
account for unknown variables affecting outcome that are
not correlated strongly with measured variables. They lack
the discipline and rigor of a randomized trial. Thus,
although they constitute the most rigorous methods avail-
able for apples-to-apples investigation of causal effects on
outcome in the nonrandomized setting, they are not as
definitive as randomized trials. 
On the other hand, they are more versatile and more
widely applicable than randomized trials. For example, one
can never randomize whether or not a person will have
chronic atrial fibrillation or be a smoker at coronary artery
bypass grafting. 
Methodologic Issues
Some investigators claim that balancing score methods are
valid only for large studies, citing Rubin.21 It is true that
large numbers facilitate certain uses of these scores, such as
stratification. Case-control matching is also better when a
large group of controls is available for matching. However,
I believe that there is considerable latitude in matching that
still reduces bias; the method seems to “work,” even for
modest-sized data sets.
Another limitation is having few variables available for
propensity modeling. The propensity score is seriously
degraded when important variables influencing selection
have not been collected.2 
The propensity score may not eliminate all selection
bias.30 This may be attributed to limitations of the modeling
itself imposed by the linear combination of factors in the
regression analysis that generates the balancing score. 
Perhaps the most important limitation is inextricable
confounding. Suppose one wishes to compare on-pump
coronary bypass grafting with off-pump operations. One
designs a study to compare the results of institution A,
which performs only off-pump bypass, with those of insti-
tution B, which performs only on-pump bypass. Even after
careful application of propensity score methods, it remains
impossible to distinguish between an institutional and a
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treatment difference because they are inextricably inter-
twined—they are the same variable!
Extensions
At times, one may wish to compare more than 2 groups,
such as groups representing 3 different valve types. Under
this circumstance, multiple propensity models are formu-
lated and used.21 I prefer to generate fully conditional mul-
tiple logistic propensity scores, although some believe this
“correctness” is not essential.31
Most applications of balancing scores have been con-
cerned with dichotomous (yes/no) comparison group vari-
ables. However, balancing scores can be extended to a
multiple-state ordered variable (ordinal) or even a continu-
ous variable.32 An example of the latter is the use of corre-
lates of the continuous value of ejection fraction as a
balancing score to isolate the possible causative influence
of left ventricular dysfunction.
Conclusions
Be suspicious of apples-to-oranges comparisons! In the
past, methods were limited for identifying apples from
among the mixed fruit so that a proper comparison could be
made. The propensity score and balancing scores in general
provide the collaborating statistician with powerful
weapons for making valid apples-to-apples comparisons in
the nonrandomized or unrandomizable setting. Their theo-
retical properties and reason for working in this fashion are
becoming increasingly clarified, as are their limitations. 
I suggest that in settings in which comparison of out-
come is based on nonrandomized clinical experience and,
therefore, the danger of apples-to-oranges comparison is
present, balancing scores should be considered and, if
appropriate, used. Because this is my recommendation,
you, the reader, need to be “clued in” to this methodology.
I hope this explanation has made you a more informed, and
less intimidated, reader!
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Appendix
This appendix is intended for the biostatistical collaborator. It is a
“how-we-do-it” (my colleagues and I) commentary, not a mathe-
matical appendix.
Propensity Model Construction
For 2-group comparisons, we construct propensity models with
the use of logistic regression. Nearly always it is useful to the
investigators and the readers to have a well-formulated explana-
tory model of the differences between patients receiving one treat-
ment rather than the other. Thus, we begin with parsimonious
model construction.
Preparatory analyses. The modeling process involves all the
well-known preparatory steps that help one get to know the data in
detail. We examine simple correlations (because medical data are
inherently redundant), construct contingency tables with respect to
the comparison variable of interest, and perform t tests for contin-
uous variables. All this is useful not only in screening variables as
possible risk factors, but also in eliminating some variables that
occur infrequently or are associated with too few events for com-
putational stability. We calibrate continuous and ordinal variables
to the event scale by transformation of scale. Only then is multi-
variable analysis begun. 
Explanatory model construction. Variables of good quality,
well understood, and appropriate for the analysis are examined
without regard to the univariable testing. This means that on occa-
sion, a univariably nonsignificant variable will become significant
in the analysis. You will have to investigate whether this is simply
an adjusting factor (that may require more work on the main vari-
able), or a variable representing a tiny subset of patients once
many variables are in the model, or a lurking variable.
We use a variety of model-building methods. Prominent among
these is so-called “bagging” using computer-intensive bootstrap-
ping.33
Propensity model construction. However, the propensity
model is not parsimonious, but is augmented with whatever is
recorded about the patients, and particularly variables that might
be related to selection.22 The object is to account for everything
known that may relate to either systematic bias, or simply bad
luck, that has otherwise unbalanced the comparison groups of
interest.17 We like to achieve a goodness-of-fit c-statistic in the 0.8
to 0.9 range. Its developers even suggest ignoring usual concerns
about model overdetermination. The most useful propensity mod-
els incorporate well-calibrated continuous variables so as to pro-
duce a smooth distribution of scores.
The one thing never considered in forming the propensity
model is the outcome of interest. All work must be done without
respect to outcome.4
A special word is needed about managing missing values for
some variables. Because of the high degree of correlation among
medical variables, some variables with missing or unreliable values
might be ignored. More commonly, methods of imputing missing
values, informative or noninformative, should be used. The object is
to be able to calculate a propensity score for each patient. We form
a set of indicator variables that identify patients who have a missing
value for a variable (at least when missing values occur in a sub-
stantial number of patients, such as 5% to 10%). These indicator
variables are included in the propensity model to distribute missing
values appropriately and reduce the bias of missing values.22,34
Propensity modeling trap. Beware of variables that are strong
surrogates for the group of interest. Some statisticians have remarked
that they see no sense in using balancing scores because they already
know which patients belong to each group! This reflects lack of
understanding of what one is trying to accomplish with the propen-
sity score. (They forget that the same statement can be made about a
logistic analysis of hospital mortality.) The object is to produce a
model for use in reducing bias of how the patients were selected for
the group they are actually in and to permit apples-to-apples com-
parisons. The danger can be subtle. For example, if the two treat-
ments being compared have been used sequentially in time, then date
of treatment (usually a good variable for propensity modeling) is a
surrogate for group membership and should not be used.
Despite attention to this detail, quasi-separation in the model-
ing may occur. One possible explanation for this occurrence is that
the variables contain all the information that has actually been
used to formulate a rules-based treatment policy. If this is the case,
no balancing score will be helpful in evaluating the rules with
respect to outcome short of a proper trial.
Alternative models. Just as there are alternatives to logistic
regression for analysis of binary outcomes, there are alternatives to
its use in forming propensity scores. Thus, any method for classifi-
cation, such as computer-aided regression trees (CART), neural
networks, or optimum discrimination, could be used.35,36 For some
of these methods, it is necessary to dichotomize the explanatory
variables, leading to a “lumpy” balancing score that is not ideal. 
Calculating the propensity score. One can use the propensity
score directly in logit units or convert it to probability. For most uses,
it makes no difference. However, it makes a difference if the propen-
sity score is used in a multivariable analysis. In that setting, treat the
propensity score as you would any other continuous variable. It may
have to be calibrated to the scale of risk by transformation.
Using the Propensity Score for Comparisons by
Multivariable Adjustment
As mentioned in the text, the propensity score for each patient can
be included in a multivariable analysis of risk factors. We first
check that we have a well-matched set of patients, as discussed in
the section “Get Rid of Oranges?” in the text. Once a well-
matched patient group is available, we have found it useful to first
perform an analysis without forcing in the variable of interest or
the propensity score. We then look at the variable of interest just
as we would do in a randomized trial, this time forcing it into the
model and noting which, if any, variables it displaces. We then
investigate all the interactions between this variable of interest and
the other variables in the model. Finally, we look with equal inten-
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sity at the propensity score in the model. This sequence of steps
relies heavily on bootstrap bagging.33
The sequential strategy described has afforded us the opportu-
nity to better understand the influence on outcome of the compar-
ison variable of interest, as well as the thoroughness of adjustment
by risk factors alone. We29 generally report the magnitude of effect
of the comparison variable of interest as the bootstrapped median.
An important consideration is interpretation of a multivariable
model when the propensity score remains statistically significant
for the multitude of reasons cited in the text. This situation, partic-
ularly in a multivariable equation that is intended for prospective
prediction, presents an interesting dilemma. All other variables in
the model relate to characteristics of individual patients, so they can
be applied to a future patient. However, the propensity score repre-
sents an attribute of the specific group of patients used in the analy-
sis. A future patient does not belong to this group! Such a mixture
of individual and group variables in the same model is an interest-
ing statistical anomaly that is incompletely understood.3
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